Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 8 of 8 for “"Protein truncation test"”.
-
Towards a general strategy for breast cancer : investigation of germline mutations of BRCA1 and BRCA2 genes in Iranian women with early-onset breast cancer
… BRCA1 exons 11 and BRCA2 exons 10 and 11 by the Protein Truncation Test (PTT) and BRCAI exons 2, 3, 5, 13 and 20 and BRCA2 exons 9, 17,18 and 23 with the Single Strand Conformation Polymorphism (SSCP)assay were analysed on genomic DNA amplified by polymerase chain reaction. Ten sequence variants …
-
BRCA1 mutations in the family history clinic
… onset and and/or ovarian cancers underwent gene testing using a combination of protein truncation test and heteroduplex analysis. Ten percent of patients (20/199) with increased familial risk were found to be mutation carriers, suggesting that gene testing may be offered to such patients in the …
-
Νέες τεχνικές πρωτεϊνικής ανάλυσης
… a method is described for preparation of protein arrays. The method is based on the in vitro expression of recombinant DNA sequences, which are produced via the polymerase chain reaction (PCR). Thus, a DNA array is converted into a protein array, facilitating the steps required for the …
-
The role of heterozygosity for ataxia telangiectasia in breast cancer
… patients for mutations in the ATM gene using the protein truncation test (PTT). No mutations were found. Although this does not confirm the association between AT and breast cancer, neither does it exclude it. A large scale sequencing exercise of the whole ATM gene may be the required next step. …
-
Μοριακή μελέτη των γονιδίων BRCA1 και BRCA2 σε Έλληνες ασθενείς με κληρονομούμενο καρκίνο μαστού και ωοθηκών
… with hereditary breast and ovarian cancer were tested with the protein truncation test (PTT) for mutations in peripheral blood DNA in exon 11 of the BRCA1 gene and exons 10 and 11 of the BRCA2 gene (60% of the coding region of both genes). Totally eight deleterious mutations were detected and …
-
Μελέτη και κλινική αξιολόγηση νέων μοριακών δεικτών καρκίνου του μαστού
… approximately 3.5Kb mRNA, which encodes aprotein of 1186 amino acids. Exons 4 and 5 are much larger than all the others (65%of the coding area). Its deleterious mutations confer a moderate breast cancer risk inheterozygotes and Fanconi anemia in biallelic mutation carriers (hence its other …
-
Caretaker-Gen-Syndrome
… Spleißen führen, wurden 20 AT-Zellinien mittels „Protein Truncation Test“ nach Deletionen oder Insertionen an den Exongrenzen durchsucht. Die 7 neu identifizierten Spleißmutationen wurden anschließend unter Verwendung eines „Splice Scoring“- Systems näher charakterisiert, die Penetranz der …
-
The Molecular Pathologies of BRCA1 in Ovarian Cancer Patients From the West of Scotland
… and contains 24 exons. The 7.8 kb mRNA encodes a protein of 1863 amino acids. The structure of BRCA1 is not strikingly homologous to other known molecules apart from the presence of a ring zinc finger domain and a 10 amino acid granin motif which are thought to be significant due to fact that they …